Symbol="XCUR"
AssetType="Common Stock"
Name="Exicure Inc"
Description="Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois."
CIK="1698530"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8045 LAMON AVE, SUITE 410, SKOKIE, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="8994200"
EBITDA="2479000"
PERatio="1.284"
PEGRatio="None"
BookValue="1.746"
DividendPerShare="0"
DividendYield="0"
EPS="0.81"
RevenuePerShareTTM="5.07"
ProfitMargin="0.0518"
OperatingMarginTTM="0.0521"
ReturnOnAssetsTTM="0.026"
ReturnOnEquityTTM="0.152"
RevenueTTM="26261000"
GrossProfitTTM="9059000"
DilutedEPSTTM="0.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="9.28"
AnalystTargetPrice="2"
TrailingPE="1.284"
ForwardPE="-"
PriceToSalesRatioTTM="0.422"
PriceToBookRatio="4.852"
EVToRevenue="21.97"
EVToEBITDA="0.126"
Beta="1.154"
num_52WeekHigh="3.24"
num_52WeekLow="0.63"
num_50DayMovingAverage="1.08"
num_200DayMovingAverage="1.153"
SharesOutstanding="8648300"
DividendDate="None"
ExDividendDate="None"
symbol="XCUR"
open="1.05"
high="1.08"
low="1.03"
price="1.07"
volume="19678.00"
latest_trading_day="2023-07-27"
previous_close="1.04"
change="0.03"
change_percent="2.8846%"
aroon_positive_momentum_days="65"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="31777"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.54"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="1098"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="1007"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0169.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
